Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
IBB vs USO: how they differ
IBB is an equity index fund and USO a commodity fund, and over the year USO returned more, +112.2% against +41.5%.
iShares Biotechnology ETF and United States Oil Fund, LP.
| IBB iShares Biotechnology ETF | USO United States Oil Fund, LP | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | iShares | United |
| What it is | Biotechnology | Oil |
| Total return, 1 year | +41.5% | +112.2% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | +24.0 pts | +94.7 pts |
| Expense ratio | 0.44% | not published |
| Holdings | 248 | not filed |
IBB in plain words
IBB is an index equity fund tracking the Biotechnology. Over the year to Sep 11, 2026 it returned +41.5% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.44% a year. By its holdings filed for Jun 30, 2026, 36% of the fund by weight is stocks the S&P 500 also holds, across 248 positions, with the top ten at 44.8%. It sat 6.5% below its high of Aug 19, 2026 on Sep 11, 2026.
USO in plain words
USO is a commodity fund tracking the Oil. Over the year to Sep 11, 2026 it returned +112.2% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. It sat 57.1% below its high of Apr 8, 2011 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, IBB or USO?
- In the year to Sep 12, 2026, with distributions reinvested, IBB returned +41.5% and USO returned +112.2%, so USO returned more. One year is one year; the longer windows are in the table.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, IBB against USO, data as of Sep 12, 2026. https://etfiq.com/compare/any/IBB-USO Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources